Julia Tamulis focuses her practice on counseling a diverse range of clients on complex healthcare regulatory issues affecting operations and compliance matters. Julia advises pediatric hospital systems on compliance issues, including daily operations matters and internal compliance audits and reviews. She also provides guidance on healthcare regulatory compliance for pharmaceutical and medical device manufacturers and distributors and health plans.
Drawing on her healthcare regulatory experience, Julia assists with internal compliance reviews and responding to government investigations, including defending companies facing government scrutiny in False Claims Act (FCA) matters. She has represented clients in the medical device, pharmaceutical, long-term care, and imaging sectors, as well as senior healthcare executives, before U.S. Attorneys’ Offices and the Department of Health and Human Services (HHS) Office of Inspector General in FCA, Stark Law, and Anti-Kickback Statute enforcement actions.
American Health Lawyers Association (AHLA) — Hospitals and Health Systems Practice Group, Vice Chair (2018-2022); Hospitals and Health Systems Practice Group, Leadership Development Program (2015-2016)
Women’s White Collar Defense Association
D.C. Bar Association — Health Law Section, Steering Committee Co-Chair (2016-2018); Health Law Section, Steering Committee (2015-2016); Health Law Section, New Practitioners Planning Committee (2014-2017)
Successfully defended a number of clients across industry sectors, including hospitals, physician practices, hospices, home health agencies and DMEPOS suppliers, in appealing audit results where statistical sampling was used to calculate to extrapolated overpayment demands.
Currently serve as outside counsel for one of the largest national hospice providers, handling audit response issues and appealing unfavorable audit results, which has resulted in overturning millions of dollars in overpayment demands.
Currently serve as outside counsel for a publicly traded senior living in responding to home health and hospice audits.
Represented Addus HomeCare Corporation in its acquisition of Ambercare for $40 million.
Represented a large hospital system and negotiated a favorable settlement with HHS-OIG utilizing the OIG’s Self-Disclosure Protocol. More specifically, our team conducted an internal investigation into possible compliance issues, drafted the disclosure for provision to HHS-OIG, and negotiated the final settlement between the parties resulting in a favorable resolution for the hospital.
Represented a global healthcare company in relation to an investigation conducted by DOJ and HHS-OIG into alleged violations of the False Claims Act. The alleged false claims involved the manner in which certain negative pressure wound therapy devices were being marketed and distributed as durable medical equipment. Conducted an internal investigation and negotiated a favorable settlement with DOJ, HHS-OIG, and counsel for the relator. No post-settlement oversight was required.
Represented Pharos Capital Group, LLC in its acquisition of an adolescent residential treatment center
Represented Medicare Advantage service provider in qui tam alleging that defendants caused inflation of risk adjustment scores. U.S. ex rel. Ramsey v. Censeo Health, L.L.C., No. 3:14-cv-118 (N.D. Tex.)
Represented Modern HC Holdings, Inc. in its sale to The Kroger Company
Represented Healthways (NASDAQ: HWAY) in the sale of its Total Population Health Services (TPHS) business to Sharecare, Inc.
Washington, D.C. Super Lawyers “Rising Star” (2016-2019)
The George Washington University Law School — J.B. and Maurice C. Shapiro Public Service Fellowship Recipient
American Intellectual Property Law Association (AIPLA) Quarterly Journal — Editorial Staff Member
University of Oxford — International Human Rights Law Program (2009)